Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555
Patient Information Leaflet last updated on the eMC: 16/04/2009
PIL Xenical 120mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/04/2009 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/06/2008 and displayed until 16/04/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/04/2008 and displayed until 30/06/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 20/02/2008 and displayed until 08/04/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 02/06/2006 and displayed until 20/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Change to date of revision
Updated on 22/06/2005 and displayed until 02/06/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 27/10/2004 and displayed until 22/06/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 21/04/2004 and displayed until 27/10/2004
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 11/12/2003 and displayed until 21/04/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 13/05/2003 and displayed until 11/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 01/08/2002 and displayed until 13/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 31/01/2002 and displayed until 01/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 31/05/2001 and displayed until 31/01/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 22/03/2001 and displayed until 31/05/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 21/03/2001 and displayed until 22/03/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   orlistat


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk